Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPC-16008703Phase 4Recruiting
Phase 4, open-label, single-arm trial of meropenem in sepsis, sponsored by Children's Hospital of Fudan University. Primary endpoint: Blood concentration of meropenem. Started Jun 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPC-16008703.